A subsequent study on high-fat diet-induced NAFLD in rats found up to 10-fold increases in miR-122 levels in the absence of serum ALT changes suggesting that serum miR-122 levels may in fact provide a biomarker for early-stage NAFLD, at least in this experimental model [62]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.